Agenus Inc.

NASDAQ: AGEN · Real-Time Price · USD
4.78
-0.36 (-7.00%)
At close: Jun 17, 2025, 3:59 PM
4.92
3.04%
After-hours: Jun 17, 2025, 05:10 PM EDT
-7.00%
Bid 4.68
Market Cap 130.92M
Revenue (ttm) 99.52M
Net Income (ttm) -190.65M
EPS (ttm) 29.61
PE Ratio (ttm) 0.16
Forward PE 4.69
Analyst Hold
Ask 4.93
Volume 601,614
Avg. Volume (20D) 996,453
Open 5.10
Previous Close 5.14
Day's Range 4.75 - 5.17
52-Week Range 1.38 - 18.74
Beta 1.43

About AGEN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AGEN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for AGEN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 week ago
+12.6%
Agenus shares are trading higher after HC Wainwrig... Unlock content with Pro Subscription
2 weeks ago
+21.07%
Agenus shares are trading higher after the company announced it signed a partnership agreement with Zydus Lifesciences to expand patient access to Botensilimab and Balstilimab.